Anthony Ferrari holds PhD in analytical chemistry and the Co-Founder & Director of Science at Sym Sciences. He has over 8 years of experience in cannabinoid formulation, manufacturing and clinical trials, leading the translational research programs at Sym Sciences.

Dr. Ferrari and his team collaborate with universities to conduct pre-clinical and IND-supported clinical trials, evaluating therapies across multiple form factors and formulations. His work has made a substantial impact across multiple indications including sleep, mental health, metabolic health, pain and substance use disorders. The primary goal of his FDA-aligned research is to uplift cannabinoid therapeutics to current standards and ultimately implement these products into broader patient care and traditional healthcare systems.

At CannMed, Dr. Ferrari will be speaking about how drinkable, water-soluble cannabinoids can be an impactful to research outcome. Sym Sciences is Gold Sponsors of the event.